Next Article in Journal
Dissecting the Crosstalk between NRF2 Signaling and Metabolic Processes in Cancer
Previous Article in Journal
Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab
 
 
Review

Article Versions Notes

Cancers 2020, 12(10), 3022; https://doi.org/10.3390/cancers12103022
Action Date Notes Link
article html file updated 18 August 2026 05:45 CEST Update https://www.mdpi.com/2072-6694/12/10/3022/html
article html file updated 24 December 2025 22:23 CET Update -
article html file updated 23 October 2025 10:37 CEST Update -
article html file updated 1 September 2025 11:11 CEST Update -
article html file updated 22 July 2022 21:29 CEST Update -
article html file updated 22 October 2020 04:31 CEST Original file -
article pdf uploaded. 22 October 2020 04:30 CEST Updated version of record https://www.mdpi.com/2072-6694/12/10/3022/pdf
article xml uploaded. 22 October 2020 04:30 CEST Update https://www.mdpi.com/2072-6694/12/10/3022/xml
article xml file uploaded 22 October 2020 04:30 CEST Original file -
article pdf uploaded. 17 October 2020 14:08 CEST Version of Record https://www.mdpi.com/2072-6694/12/10/3022/pdf-vor
Back to TopTop